Ohr Pharmaceutical logo

OHRP Ohr Pharmaceutical

Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.

Health Technology Biotechnology SIC: Unknown CIK: 1173281

Auditor raised Going Concern issues

Transaction DateRecipientSharesTypePriceValue